Clinical pharmacology of thalidomide.
Trapnell
C B
CB
Food and Drug Administration, Center for Biologics Evaluatiion and Research, Bethesda, MD.
D019247:HIV Wasting Syndrome / Q000188:drug therapy*; D006207:Half-Life; D006801:Humans; D006868:Hydrolysis; D013237:Stereoisomerism; D013723:Teratogens; D013792:Thalidomide / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*
D013723:Teratogens; D013792:Thalidomide